SERA Sera Prognostics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SERA

Price (delayed)

$9.75

Market cap

$316.15M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.16

Enterprise value

$313.55M

Highlights
Sera Prognostics's debt has decreased by 45% YoY and by 17% from the previous quarter
Sera Prognostics's gross profit has increased by 28% YoY and by 13% QoQ
Sera Prognostics's revenue has increased by 14% YoY but it has decreased by 7% from the previous quarter
The quick ratio has plunged by 57% YoY and by 27% from the previous quarter
The equity has declined by 29% year-on-year and by 7% since the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Peers: SHC

Key stats

What are the main financial stats of SERA
Market
Shares outstanding
32.43M
Market cap
$316.15M
Enterprise value
$313.55M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.35
Price to sales (P/S)
994.14
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1,024.67
Earnings
Revenue
$306,000
EBIT
-$36.19M
EBITDA
-$34.76M
Free cash flow
-$27.01M
Per share
EPS
-$1.16
Free cash flow per share
-$0.87
Book value per share
$2.24
Revenue per share
$0.01
TBVPS
$3.06
Balance sheet
Total assets
$95.44M
Total liabilities
$25.28M
Debt
$1.28M
Equity
$70.16M
Working capital
$36.9M
Liquidity
Debt to equity
0.02
Current ratio
2.51
Quick ratio
2.48
Net debt/EBITDA
0.07
Margins
EBITDA margin
-11,359.8%
Gross margin
31.4%
Net margin
-11,843.8%
Operating margin
-13,013.4%
Efficiency
Return on assets
-37.4%
Return on equity
-45.7%
Return on invested capital
-56.7%
Return on capital employed
-51%
Return on sales
-11,825.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SERA stock price

How has the Sera Prognostics stock price performed over time
Intraday
0.72%
1 week
-13.33%
1 month
8.82%
1 year
198.17%
YTD
63.04%
QTD
7.14%

Financial performance

How have Sera Prognostics's revenue and profit performed over time
Revenue
$306,000
Gross profit
$96,000
Operating income
-$39.82M
Net income
-$36.24M
Gross margin
31.4%
Net margin
-11,843.8%
Sera Prognostics's net margin has increased by 28% YoY but it has decreased by 2.7% from the previous quarter
Sera Prognostics's gross profit has increased by 28% YoY and by 13% QoQ
Sera Prognostics's operating margin has increased by 24% YoY but it has decreased by 3.8% QoQ
The gross margin has grown by 22% from the previous quarter and by 12% YoY

Growth

What is Sera Prognostics's growth rate over time

Valuation

What is Sera Prognostics stock price valuation
P/E
N/A
P/B
4.35
P/S
994.14
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1,024.67
SERA's EPS is up by 19% year-on-year and by 6% since the previous quarter
The price to book (P/B) is 188% higher than the last 4 quarters average of 1.5
The equity has declined by 29% year-on-year and by 7% since the previous quarter
SERA's P/S is 178% above its last 4 quarters average of 354.8
Sera Prognostics's revenue has increased by 14% YoY but it has decreased by 7% from the previous quarter

Efficiency

How efficient is Sera Prognostics business performance
SERA's return on sales is up by 28% year-on-year but it is down by 2.7% since the previous quarter
The company's return on equity fell by 16% YoY and by 3.9% QoQ
The ROIC has grown by 12% YoY and by 2.9% from the previous quarter
The company's return on assets fell by 4.2% YoY

Dividends

What is SERA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SERA.

Financial health

How did Sera Prognostics financials performed over time
Sera Prognostics's total liabilities has surged by 73% QoQ and by 45% YoY
The quick ratio has plunged by 57% YoY and by 27% from the previous quarter
Sera Prognostics's debt is 98% less than its equity
Sera Prognostics's debt has decreased by 45% YoY and by 17% from the previous quarter
The equity has declined by 29% year-on-year and by 7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.